These studies sought to determine whether a progestational agent, specifically medroxyprogesterone acetate (MPA) prevents inflammation-induced preterm birth, in a mouse model, through modulation of the host immune response.
Center for Research in Reproduction and Women's Health, Department of Obstetrics & Gynecology, University of Pennsylvania, Philadelphia, Pennsylvania, USA. melovitz@obgyn.upenn.edu
